Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
vol.32 iss.2 (2025) pp.10 Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
vol.32 iss.2 (2025) pp.18 BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate
vol.32 iss.2 (2025) pp.18 Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
vol.32 iss.2 (2025) pp.19 Ectopic expression of DNMT3L in human trophoblast stem cells restores features of the placental methylome
vol.32 iss.2 (2025) pp.17 Human adult neurogenesis loss corresponds with cognitive decline during epilepsy progression
vol.32 iss.2 (2025) pp.9 Longitudinal single-cell profiles of lung regeneration after viral infection reveal persistent injury-associated cell states
vol.32 iss.2 (2025) pp.20 Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation
vol.32 iss.2 (2025) pp.4 Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP
vol.32 iss.2 (2025) pp.3 Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
vol.32 iss.2 (2025) pp.3 Engineered hiPSC-derived vascular graft brings hope for thrombosis-free vascular therapy
vol.32 iss.1 (2025) pp.3 All-in-one gene therapy alternative for DBAS
vol.32 iss.1 (2025) pp.3 Perceiving the brain like never before
vol.32 iss.1 (2025) pp.3 Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
vol.32 iss.1 (2025) pp.28 Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia
vol.32 iss.1 (2025) pp.15 Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response
vol.32 iss.1 (2025) pp.18 Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model
vol.32 iss.1 (2025) pp.19 Photo-tunable hydrogels reveal cellular sensing of rapid rigidity changes through the accumulation of mechanical signaling molecules
vol.32 iss.1 (2025) pp.16 Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency
vol.32 iss.1 (2025) pp.7 m6A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs
vol.32 iss.1 (2025) pp.13 Generation of self-organized neuromusculoskeletal tri-tissue organoids from human pluripotent stem cells
vol.32 iss.1 (2025) pp.15 Different effects of fatty acid oxidation on hematopoietic stem cells based on age and diet
iss.Preprints (2025) Generation of human expandable limb-bud-like progenitors via chemically induced dedifferentiation
vol.31 iss.12 (2024) pp.9 Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
vol.31 iss.12 (2024) pp.19 Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance
vol.31 iss.12 (2024) pp.17 Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice
vol.31 iss.12 (2024) pp.19 A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration
vol.31 iss.12 (2024) pp.18 Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis
vol.31 iss.11 (2024) pp.17 Embryonic macrophages support endocrine commitment during human pancreatic differentiation
vol.31 iss.11 (2024) pp.21 Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
vol.31 iss.11 (2024) pp.18 A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice
vol.31 iss.11 (2024) pp.20 Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
vol.31 iss.11 (2024) pp.17 Modeling the atrioventricular conduction axis using human pluripotent stem cell-derived cardiac assembloids
vol.31 iss.11 (2024) pp.18 Alveolar regeneration by airway secretory-cell-derived p63+ progenitors
vol.31 iss.11 (2024) pp.16 Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
vol.31 iss.11 (2024) pp.13 Common and uncommon findings in marmoset and human trophoblast stem cells
vol.31 iss.10 (2024) pp.2 Let’s get functional: Drug sensitivity profiling to enable precision sarcoma medicine
vol.31 iss.10 (2024) pp.2 Charles “Chuck” K.F. Chan (1975–2024)
vol.31 iss.10 (2024) pp.2 Effective regulatory responses to predatory stem cell markets in Australia and Canada
vol.31 iss.10 (2024) pp.5 Early human development and stem cell-based human embryo models
vol.31 iss.10 (2024) pp.21 Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism
vol.31 iss.10 (2024) pp.8 Marmoset and human trophoblast stem cells differ in signaling requirements and recapitulate divergent modes of trophoblast invasion
vol.31 iss.10 (2024) pp.20 Inflammation-induced epigenetic imprinting regulates intestinal stem cells
vol.31 iss.10 (2024) pp.18 Context-dependent roles of mitochondrial LONP1 in orchestrating the balance between airway progenitor versus progeny cells
vol.31 iss.10 (2024) pp.19 Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury
vol.31 iss.10 (2024) pp.17 Generation of human region-specific brain organoids with medullary spinal trigeminal nuclei
vol.31 iss.10 (2024) pp.12 Human pluripotent stem cell-derived organoids repair damaged bowel in vivo
vol.31 iss.10 (2024) pp.11 The landscape of drug sensitivity and resistance in sarcoma
vol.31 iss.10 (2024) pp.19 A one-way street recognition approach to mediate allogeneic immune cell therapies
vol.31 iss.9 (2024) pp.2 Acetate to the rescue: Acetyl-CoA facilitates placental development
vol.31 iss.9 (2024) pp.3
vol.32 iss.2 (2025) pp.10 Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
vol.32 iss.2 (2025) pp.18 BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate
vol.32 iss.2 (2025) pp.18 Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
vol.32 iss.2 (2025) pp.19 Ectopic expression of DNMT3L in human trophoblast stem cells restores features of the placental methylome
vol.32 iss.2 (2025) pp.17 Human adult neurogenesis loss corresponds with cognitive decline during epilepsy progression
vol.32 iss.2 (2025) pp.9 Longitudinal single-cell profiles of lung regeneration after viral infection reveal persistent injury-associated cell states
vol.32 iss.2 (2025) pp.20 Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation
vol.32 iss.2 (2025) pp.4 Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP
vol.32 iss.2 (2025) pp.3 Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
vol.32 iss.2 (2025) pp.3 Engineered hiPSC-derived vascular graft brings hope for thrombosis-free vascular therapy
vol.32 iss.1 (2025) pp.3 All-in-one gene therapy alternative for DBAS
vol.32 iss.1 (2025) pp.3 Perceiving the brain like never before
vol.32 iss.1 (2025) pp.3 Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
vol.32 iss.1 (2025) pp.28 Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia
vol.32 iss.1 (2025) pp.15 Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response
vol.32 iss.1 (2025) pp.18 Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model
vol.32 iss.1 (2025) pp.19 Photo-tunable hydrogels reveal cellular sensing of rapid rigidity changes through the accumulation of mechanical signaling molecules
vol.32 iss.1 (2025) pp.16 Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency
vol.32 iss.1 (2025) pp.7 m6A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs
vol.32 iss.1 (2025) pp.13 Generation of self-organized neuromusculoskeletal tri-tissue organoids from human pluripotent stem cells
vol.32 iss.1 (2025) pp.15 Different effects of fatty acid oxidation on hematopoietic stem cells based on age and diet
iss.Preprints (2025) Generation of human expandable limb-bud-like progenitors via chemically induced dedifferentiation
vol.31 iss.12 (2024) pp.9 Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
vol.31 iss.12 (2024) pp.19 Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance
vol.31 iss.12 (2024) pp.17 Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice
vol.31 iss.12 (2024) pp.19 A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration
vol.31 iss.12 (2024) pp.18 Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis
vol.31 iss.11 (2024) pp.17 Embryonic macrophages support endocrine commitment during human pancreatic differentiation
vol.31 iss.11 (2024) pp.21 Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
vol.31 iss.11 (2024) pp.18 A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice
vol.31 iss.11 (2024) pp.20 Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
vol.31 iss.11 (2024) pp.17 Modeling the atrioventricular conduction axis using human pluripotent stem cell-derived cardiac assembloids
vol.31 iss.11 (2024) pp.18 Alveolar regeneration by airway secretory-cell-derived p63+ progenitors
vol.31 iss.11 (2024) pp.16 Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
vol.31 iss.11 (2024) pp.13 Common and uncommon findings in marmoset and human trophoblast stem cells
vol.31 iss.10 (2024) pp.2 Let’s get functional: Drug sensitivity profiling to enable precision sarcoma medicine
vol.31 iss.10 (2024) pp.2 Charles “Chuck” K.F. Chan (1975–2024)
vol.31 iss.10 (2024) pp.2 Effective regulatory responses to predatory stem cell markets in Australia and Canada
vol.31 iss.10 (2024) pp.5 Early human development and stem cell-based human embryo models
vol.31 iss.10 (2024) pp.21 Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism
vol.31 iss.10 (2024) pp.8 Marmoset and human trophoblast stem cells differ in signaling requirements and recapitulate divergent modes of trophoblast invasion
vol.31 iss.10 (2024) pp.20 Inflammation-induced epigenetic imprinting regulates intestinal stem cells
vol.31 iss.10 (2024) pp.18 Context-dependent roles of mitochondrial LONP1 in orchestrating the balance between airway progenitor versus progeny cells
vol.31 iss.10 (2024) pp.19 Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury
vol.31 iss.10 (2024) pp.17 Generation of human region-specific brain organoids with medullary spinal trigeminal nuclei
vol.31 iss.10 (2024) pp.12 Human pluripotent stem cell-derived organoids repair damaged bowel in vivo
vol.31 iss.10 (2024) pp.11 The landscape of drug sensitivity and resistance in sarcoma
vol.31 iss.10 (2024) pp.19 A one-way street recognition approach to mediate allogeneic immune cell therapies
vol.31 iss.9 (2024) pp.2 Acetate to the rescue: Acetyl-CoA facilitates placental development
vol.31 iss.9 (2024) pp.3
